Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
- PMID: 21051638
- DOI: 10.1126/science.1195300
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha
Abstract
The stromal microenvironment of tumors, which is a mixture of hematopoietic and mesenchymal cells, suppresses immune control of tumor growth. A stromal cell type that was first identified in human cancers expresses fibroblast activation protein-α (FAP). We created a transgenic mouse in which FAP-expressing cells can be ablated. Depletion of FAP-expressing cells, which made up only 2% of all tumor cells in established Lewis lung carcinomas, caused rapid hypoxic necrosis of both cancer and stromal cells in immunogenic tumors by a process involving interferon-γ and tumor necrosis factor-α. Depleting FAP-expressing cells in a subcutaneous model of pancreatic ductal adenocarcinoma also permitted immunological control of growth. Therefore, FAP-expressing cells are a nonredundant, immune-suppressive component of the tumor microenvironment.
Comment in
-
Cancer. Awakening immunity.Science. 2010 Nov 5;330(6005):761-2. doi: 10.1126/science.1198345. Science. 2010. PMID: 21051618 No abstract available.
Similar articles
-
The application of the fibroblast activation protein α-targeted immunotherapy strategy.Oncotarget. 2016 May 31;7(22):33472-82. doi: 10.18632/oncotarget.8098. Oncotarget. 2016. PMID: 26985769 Free PMC article. Review.
-
A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts.Sci Rep. 2015 Sep 23;5:14421. doi: 10.1038/srep14421. Sci Rep. 2015. PMID: 26394925 Free PMC article.
-
The carcinoma-associated fibroblast expressing fibroblast activation protein and escape from immune surveillance.Cancer Immunol Res. 2014 Mar;2(3):187-93. doi: 10.1158/2326-6066.CIR-14-0002. Cancer Immunol Res. 2014. PMID: 24778314
-
Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1.Cancer Immunol Res. 2014 Feb;2(2):121-6. doi: 10.1158/2326-6066.CIR-13-0150. Epub 2013 Nov 18. Cancer Immunol Res. 2014. PMID: 24778275 Free PMC article.
-
Fibroblast activation protein-α: a key modulator of the microenvironment in multiple pathologies.Int Rev Cell Mol Biol. 2012;297:83-116. doi: 10.1016/B978-0-12-394308-8.00003-0. Int Rev Cell Mol Biol. 2012. PMID: 22608558 Review.
Cited by
-
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC.Front Immunol. 2024 May 16;15:1341079. doi: 10.3389/fimmu.2024.1341079. eCollection 2024. Front Immunol. 2024. PMID: 38817612 Free PMC article. Review.
-
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer.Mol Cancer. 2024 May 7;23(1):92. doi: 10.1186/s12943-024-01990-4. Mol Cancer. 2024. PMID: 38715072 Free PMC article. Review.
-
Development and Characterization of Novel FAP-Targeted Theranostic Pairs: A Bench-to-Bedside Study.Research (Wash D C). 2023 Nov 28;6:0282. doi: 10.34133/research.0282. eCollection 2023. Research (Wash D C). 2023. PMID: 38706713 Free PMC article.
-
Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.Sci Adv. 2024 Apr 19;10(16):eadk8805. doi: 10.1126/sciadv.adk8805. Epub 2024 Apr 17. Sci Adv. 2024. PMID: 38630822 Free PMC article.
-
The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts.Int J Nanomedicine. 2024 Apr 8;19:3333-3365. doi: 10.2147/IJN.S447350. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38617796 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous